Schulman S, Gross PL, Ritchie B, Nahirniak S, Lin Y, Lieberman L, et al.Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate. Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage. Dybdahl D, Walliser G, Chance Spalding M, Pershing M, Kincaid M.

Haematological management of major bleeding associated with direct oral anticoagulants - UK experience. Green L, Tan J, Antoniou S, Alikhan R, Curry N, Everington T, et al.Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, et al.Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M.Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, et al.Richtlijn Antitrombotisch beleid – Bloeding of ingreep bij DOAC’s. Nederlandse Internisten Vereniging (NIV).Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants. Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma.

Ersayin A, Thomas A, Seyve L, Thielens N, Castellan M, Marlu R, et al.

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al.Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Schulman S, Kearon C Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry.

Testa S, Ageno W, Antonucci E, Morandini R, Beyer-Westendorf J, Paciaroni M, et al.

Praxbind mechanism of action